Reference:
Michels, C. A., Perrier, D., Kunadhasan, J., Clark, E., Gehrett, J., Gehrett, B., Kwiatek, K., Adams, S., Chandler, R., Stagno, L. A., Damian, T., Delph, E., & Flowers, C. (2023). Forensic analysis of the 38 subject deaths in the 6-month interim report of the Pfizer/BioNTech BNT162b2 mRNA vaccine clinical trial. Preprints. https://doi.org/10.20944/preprints202309.0131.v1
Summary:
This forensic analysis examines the deaths of 38 participants in the Pfizer/BioNTech BNT162b2 mRNA vaccine clinical trial over a six-month period. The study identified no significant differences in mortality
rates between the vaccinated and placebo groups during the initial 20 weeks. However, a concerning 3.7-fold increase in deaths due to cardiovascular events among vaccinated subjects was uncovered, which Pfizer/BioNTech did not report. The findings reveal discrepancies in data reporting and suggest that critical safety signals related to cardiovascular events were overlooked. This analysis emphasises the need for transparency in clinical trial data and the importance of independent reviews to ensure public safety.